David S. Bredt

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Will Sandberg (talk | contribs) at 02:44, 3 February 2020. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

David S. Bredt is an American molecular neuroscientist who has been Global Head Discovery Neuroscience at Johnson & Johnson since 2011.[1]

After studies in chemistry at Princeton, Bredt studied medicine at Johns Hopkins School of Medicine where he obtained M.D and Ph.D degrees. He was a student of Solomon H. Snyder, with whom he also co-authored several widely cited papers.[2] He worked as a postdoctoral fellow in the Department of Neuroscience at Johns Hopkins from 1993 to 1994.[3] He became a 1995 Searle scholar,[4] and received a 1997 Beckman Young Investigators Award.[5]

He worked at the University of California, San Francisco Medical school from 1994 to 2004, first as an assistant professor,[2] later as professor of physiology.[3]

He served as Vice President of Integrative Biology at Eli Lilly and Company from 2004 to 2011.[6] He was elected to the Johns Hopkins University Society of Scholars in 2005.[3][7]

Selected papers

References

  1. ^ Jonathan D. Rockoff (3 March 2011 J&J Poaches Lilly’s Neurological Research Chief Wall Street Journal. Retrieved 16 December 2013
  2. ^ a b Karen Kreeger (2 May 1992) Hot Scientists Have Philosophies In Common The Scientist
  3. ^ a b c Society of Scholars Inducts New Members The JHU Gazette. 23 May 2005. Retrieved 16 December 2013
  4. ^ Scholar Profile David S. Bredt
  5. ^ "David S. Bredt". Arnold and Mabel Beckman Foundation. Retrieved 1 August 2018.
  6. ^ Jonathan D. Rockoff (24 February 2011) Lilly’s Neuroscience Research Chief Resigns Wall Street Journal. Retrieved 16 December 2013
  7. ^ Julie Blanker (September 2005) Alumni NotesAlumni Notes Johns Hopkins Magazine. Retrieved 16 December 2013